Literature DB >> 3052632

Does the chemical instability of aspartyl and asparaginyl residues in proteins contribute to erythrocyte aging? The role of protein carboxyl methylation reactions.

J Lowenson1, S Clarke.   

Abstract

As erythrocytes age in the circulation, their proteins are subjected to a wide variety of spontaneous reactions that lead to the formation of covalent derivatives. In this article, we concentrate on nonenzymatic reactions at aspartyl and asparaginyl residues, both of which are especially vulnerable targets on the protein. These residues can be altered by a combination of deamidation, isomerization, and racemization reactions that form D- and L-aspartyl and D- and L-isoaspartyl residues. We present evidence that two of these modified residues are targets for an enzymatic methyl esterification reaction, and that methylation may represent the means by which cells respond to this type of protein damage. The metabolic fate of the methyl ester is unclear, but in vitro model studies with peptides and proteins suggest that this methylation can lead to the partial repair of the altered protein and can mitigate the loss of protein function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052632

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  9 in total

1.  Band 3 protein degradation by calpain is enhanced in erythrocytes of old people.

Authors:  N Schwarz-Ben Meir; T Glaser; N S Kosower
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

2.  Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.

Authors:  P A Cloos; C Fledelius
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  Age estimation based on aspartic acid racemization in dentine: what about caries-affected teeth?

Authors:  Nazan Sirin; Christian Matzenauer; Alexandra Reckert; Stefanie Ritz-Timme
Journal:  Int J Legal Med       Date:  2017-08-19       Impact factor: 2.686

Review 4.  Protein damage and methylation-mediated repair in the erythrocyte.

Authors:  P Galletti; D Ingrosso; C Manna; G Clemente; V Zappia
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

5.  Age estimation in biopsy specimens of dentin.

Authors:  S Ritz; R Stock; H W Schütz; H J Kaatsch
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

6.  Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures.

Authors:  Katharina Diepold; Katrin Bomans; Michael Wiedmann; Boris Zimmermann; Andreas Petzold; Tilman Schlothauer; Robert Mueller; Bernd Moritz; Jan Olaf Stracke; Michael Mølhøj; Dietmar Reusch; Patrick Bulau
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes.

Authors:  Markus Haberger; Katrin Bomans; Katharina Diepold; Michaela Hook; Jana Gassner; Tilman Schlothauer; Adrian Zwick; Christian Spick; Jochen Felix Kepert; Brigitte Hienz; Michael Wiedmann; Hermann Beck; Philipp Metzger; Michael Mølhøj; Constanze Knoblich; Ulla Grauschopf; Dietmar Reusch; Patrick Bulau
Journal:  MAbs       Date:  2014-01-17       Impact factor: 5.857

Review 8.  The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes.

Authors:  Jon D Piganelli; Mark J Mamula; Eddie A James
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

9.  Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions.

Authors:  Ingrid Schmid; Lea Bonnington; Monika Gerl; Katrin Bomans; Anna Louisa Thaller; Katharina Wagner; Tilman Schlothauer; Roberto Falkenstein; Boris Zimmermann; Jürgen Kopitz; Max Hasmann; Frieder Bauss; Markus Haberger; Dietmar Reusch; Patrick Bulau
Journal:  Commun Biol       Date:  2018-04-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.